Cytolytic CD4⁺ T cells in viral immunity

References

• Claman HN, Chaperon EA. Immunologic complementation between thymus and marrow cells – a model for the two-cell theory of immunocompetence. Transplant Rev.1, 92–113 (1969).
   PubMedGoogle Scholar
• Geha RS, Schneeberger E, Rosen FS, Merler E. Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes. J. Exp. Med.138(5), 1230–1247 (1973).
   PubMed Web of Science ®Google Scholar
• Reinherz EL, Schlossman SF. The differentiation and function of human T lymphocytes. Cell19(4), 821–827 (1980).
   PubMed Web of Science ®Google Scholar
• Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl Acad. Sci. USA76(8), 4061–4065 (1979).
   PubMed Web of Science ®Google Scholar
• Feighery C, Stastny P. HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J. Exp. Med.149(2), 485–494 (1979).
   PubMed Web of Science ®Google Scholar
• Meuer SC, Schlossman SF, Reinherz EL. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc. Natl Acad. Sci. USA79(14), 4395–4399 (1982).
   PubMed Web of Science ®Google Scholar
• Krensky AM, Reiss CS, Mier JW, Strominger JL, Burakoff SJ. Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc. Natl Acad. Sci. USA79(7), 2365–2369 (1982).
   PubMed Web of Science ®Google Scholar
• Fleischer B. Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture. Nature308(5957), 365–367 (1984).
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol.136(7), 2348–2357 (1986).
   PubMed Web of Science ®Google Scholar
• Douek DC, Brenchley JM, Betts MR et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature417(6884), 95–98 (2002).
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol.28, 445–489 (2010).
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol.21, 713–758 (2003).
   PubMed Web of Science ®Google Scholar
• Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol.10(4), 225–235 (2010).
   PubMed Web of Science ®Google Scholar
• Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity30(3), 324–335 (2009).
   PubMed Web of Science ®Google Scholar
• King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol.26, 741–766 (2008).
   PubMed Web of Science ®Google Scholar
• Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science324(5934), 1572–1576 (2009).
   PubMed Web of Science ®Google Scholar
• Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science324(5934), 1569–1572 (2009).
   PubMed Web of Science ®Google Scholar
• Chevalier MF, Julg B, Pyo A et al. HIV-1-specific IL-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J. Virol. DOI:10.1128/JVI.02030-10 (2010) (Epub ahead of print).
   Google Scholar
• Suto A, Kashiwakuma D, Kagami S et al. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med.205(6), 1369–1379 (2008).
   PubMed Web of Science ®Google Scholar
• Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med.204(8), 1849–1861 (2007).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature441(7090), 235–238 (2006).
   PubMed Web of Science ®Google Scholar
• Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell126(6), 1121–1133 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang H, Chess L. Regulation of immune responses by T cells. N. Engl. J. Med.354(11), 1166–1176 (2006).
   PubMed Web of Science ®Google Scholar
• Wing K, Fehervari Z, Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int. Immunol.18(7), 991–1000 (2006).
   PubMed Web of Science ®Google Scholar
• Omiya R, Buteau C, Kobayashi H, Paya CV, Celis E. Inhibition of EBV-induced lymphoproliferation by CD4+ T cells specific for an MHC class II promiscuous epitope. J. Immunol.169(4), 2172–2179 (2002).
   PubMed Web of Science ®Google Scholar
• Aslan N, Yurdaydin C, Wiegand J et al. Cytotoxic CD4 T cells in viral hepatitis. J. Viral Hepat.13(8), 505–514 (2006).
   PubMed Web of Science ®Google Scholar
• Nemes E, Bertoncelli L, Lugli E et al. Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. AIDS24(7), 947–957 (2010).
   PubMed Web of Science ®Google Scholar
• Jellison ER, Kim S-K, Welsh RM. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol.174(2), 614–618 (2005).
   PubMed Web of Science ®Google Scholar
• Mahon BP, Katrak K, Nomoto A, Macadam AJ, Minor PD, Mills KH. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med.181(4), 1285–1292 (1995).
   PubMed Web of Science ®Google Scholar
• Graham MB, Braciale VL, Braciale TJ. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med.180(4), 1273–1282 (1994).
   PubMed Web of Science ®Google Scholar
• Brien JD, Uhrlaub JL, Nikolich-Zugich J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol.181(12), 8568–8575 (2008).
   PubMed Web of Science ®Google Scholar
• Landais E, Saulquin X, Scotet E et al. Direct killing of Epstein–Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Blood103(4), 1408–1416 (2004).
   PubMed Web of Science ®Google Scholar
• Paludan C, Bickham K, Nikiforow S et al. Epstein–Barr nuclear antigen 1-specific CD4+ Th1 cells kill Burkitt’s lymphoma cells. J. Immunol.169(3), 1593–1603 (2002).
   PubMed Web of Science ®Google Scholar
• Klucar P, Barnes PF, Kong Y et al. Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen. Hum. Immunol.69(8), 475–483 (2008).
   PubMed Web of Science ®Google Scholar
• Echchakir H, Bagot M, Dorothee G et al. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. J. Invest. Dermatol.115(1), 74–80 (2000).
   PubMed Web of Science ®Google Scholar
• Appay V, Zaunders JJ, Papagno L et al. Characterization of CD4+ CTLs ex vivo. J. Immunol.168(11), 5954–5958 (2002).
   PubMed Web of Science ®Google Scholar
• Gamadia LE, Rentenaar RJ, van Lier RAW, ten Berge IJM. Properties of CD4+ T cells in human cytomegalovirus infection. Hum. Immunol.65(5), 486–492 (2004).
   PubMed Web of Science ®Google Scholar
• Saez-Borderias A, Guma M, Angulo A, Bellosillo B, Pende D, Lopez-Botet M. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur. J. Immunol.36(12), 3198–3206 (2006).
   PubMed Web of Science ®Google Scholar
• Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J. Exp. Med.197(4), 437–449 (2003).
   PubMed Web of Science ®Google Scholar
• van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J. Immunol.173(11), 6719–6726 (2004).
   PubMed Web of Science ®Google Scholar
• Markiewicz MA, Carayannopoulos LN, Naidenko OV et al. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J. Immunol.175(5), 2825–2833 (2005).
   PubMed Web of Science ®Google Scholar
• Roberts AI, Lee L, Schwarz E et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol.167(10), 5527–5530 (2001).
   PubMed Web of Science ®Google Scholar
• Snyder MR, Weyand CM, Goronzy JJ. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol.25(1), 25–32 (2004).
   PubMed Web of Science ®Google Scholar
• van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. Cytotoxic human CD4+ T cells. Curr. Opin. Immunol.20(3), 339–343 (2008).
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood104(9), 2840–2848 (2004).
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity21(4), 589–601 (2004).
   PubMed Web of Science ®Google Scholar
• Janssens W, Carlier V, Wu B, VanderElst L, Jacquemin MG, Saint-Remy J-MR. CD4+CD25+ T cells lyse antigen-presenting B cells by Fas–Fas ligand interaction in an epitope-specific manner. J. Immunol.171(9), 4604–4612 (2003).
   PubMed Web of Science ®Google Scholar
• Boissonnas A, Scholer-Dahirel A, Simon-Blancal V et al. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity32(2), 266–278 (2010).
   PubMed Web of Science ®Google Scholar
• Green DR, Ferguson TA. The role of Fas ligand in immune privilege. Nat. Rev. Mol. Cell Biol.2(12), 917–924 (2001).
   PubMed Web of Science ®Google Scholar
• Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol.2(10), 735–747 (2002).
   PubMed Web of Science ®Google Scholar
• Stalder T, Hahn S, Erb P. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J. Immunol.152(3), 1127–1133 (1994).
   PubMed Web of Science ®Google Scholar
• Zajac AJ, Quinn DG, Cohen PL, Frelinger JA. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc. Natl Acad. Sci. USA93(25), 14730–14735 (1996).
   PubMed Web of Science ®Google Scholar
• Stuller KA, Cush SS, Flano E. Persistent herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations. J. Immunol.184(7), 3850–3856 (2010).
   PubMed Web of Science ®Google Scholar
• Casazza JP, Betts MR, Price DA et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med.203(13), 2865–2877 (2006).
   PubMed Web of Science ®Google Scholar
• Stuller KA, Flano E. CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection. J. Virol.83(9), 4700–4703 (2009).
   PubMed Web of Science ®Google Scholar
• Sun Q, Burton RL, Lucas KG. Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein–Barr virus-specific T-cell cultures. Blood99(9), 3302–3309 (2002).
   PubMed Web of Science ®Google Scholar
• Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4+ and CD8+ T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J. Immunol.167(5), 2734–2742 (2001).
   PubMed Web of Science ®Google Scholar
• Lum JJ, Pilon AA, Sanchez-Dardon J et al. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l. J. Virol.75(22), 11128–11136 (2001).
   PubMed Web of Science ®Google Scholar
• Sedger LM, Shows DM, Blanton RA et al. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol.163(2), 920–926 (1999).
   PubMed Web of Science ®Google Scholar
• Kaplan MJ, Ray D, Mo RR, Yung RL, Richardson BC. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J. Immunol.164(6), 2897–2904 (2000).
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Yamaguchi N, Nakayama M et al. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J. Immunol.162(5), 2639–2647 (1999).
   PubMed Web of Science ®Google Scholar
• Li X, McKinstry KK, Swain SL, Dalton DK. IFN-γ acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol.179(2), 939–949 (2007).
   PubMed Web of Science ®Google Scholar
• Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science274(5288), 787–789 (1996).
   PubMed Web of Science ®Google Scholar
• Wang L, Du F, Wang X. TNF-α induces two distinct caspase-8 activation pathways. Cell133(4), 693–703 (2008).
   PubMed Web of Science ®Google Scholar
• Kim PK, Zamora R, Petrosko P, Billiar TR. The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol.1(8), 1421–1441 (2001).
   PubMed Web of Science ®Google Scholar
• Graubert TA, DiPersio JF, Russell JH, Ley TJ. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J. Clin. Invest.100(4), 904–911 (1997).
   PubMed Web of Science ®Google Scholar
• Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol.10(5), 581–587 (1998).
   PubMed Web of Science ®Google Scholar
• Yanai F, Ishii E, Kojima K et al. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J. Immunol.170(4), 2205–2213 (2003).
   PubMed Web of Science ®Google Scholar
• Brown DM, Kamperschroer C, Dilzer AM, Roberts DM, Swain SL. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell. Immunol.257(1–2), 69–79 (2009).
   PubMed Web of Science ®Google Scholar
• Brown DM, Dilzer AM, Meents DL, Swain SL. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol.177(5), 2888–2898 (2006).
   PubMed Web of Science ®Google Scholar
• Intlekofer AM, Takemoto N, Wherry EJ et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol.6(12), 1236–1244 (2005).
   PubMed Web of Science ®Google Scholar
• Hamilton SE, Jameson SC. CD8+ T cell differentiation: choosing a path through T-bet. Immunity27(2), 180–182 (2007).
   PubMed Web of Science ®Google Scholar
• Appay V, Bosio A, Lokan S et al. Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages. J. Immunol.179(11), 7406–7414 (2007).
   PubMed Web of Science ®Google Scholar
• Suto A, Wurster AL, Reiner SL, Grusby MJ. IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol.177(6), 3721–3727 (2006).
   PubMed Web of Science ®Google Scholar
• Pearce EL, Mullen AC, Martins GA et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science302(5647), 1041–1043 (2003).
   PubMed Web of Science ®Google Scholar
• Hidalgo LG, Einecke G, Allanach K, Halloran PF. The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4+ CTL, CD8+ CTL and NK cells. Am. J. Transplant.8(3), 627–636 (2008).
   PubMedGoogle Scholar
• Cruz-Guilloty F, Pipkin ME, Djuretic IM et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med.206(1), 51–59 (2009).
   PubMed Web of Science ®Google Scholar
• Kohu K, Ohmori H, Wong WF et al. The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3. J. Immunol.183(12), 7817–7824 (2009).
   PubMed Web of Science ®Google Scholar
• Yagi R, Junttila IS, Wei G et al. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-γ. Immunity32(4), 507–517 (2010).
   PubMed Web of Science ®Google Scholar
• Brown DM. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol.262(2), 89–95 (2010).
   PubMed Web of Science ®Google Scholar
• Janas ML, Groves P, Kienzle N, Kelso A. IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation. J. Immunol.175(12), 8003–8010 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang J, Scordi I, Smyth MJ, Lichtenheld MG. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J. Exp. Med.190(9), 1297–1308 (1999).
   PubMed Web of Science ®Google Scholar
• Ye W, Young JD, Liu CC. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. Cell Immunol.174(1), 54–62 (1996).
   PubMed Web of Science ®Google Scholar
• White L, Krishnan S, Strbo N et al. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood109(9), 3873–3880 (2007).
   PubMed Web of Science ®Google Scholar
• Ebert EC. Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes. Immunology127(2), 206–215 (2009).
   PubMed Web of Science ®Google Scholar
• Picker LJ, Reed-Inderbitzin EF, Hagen SI et al. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J. Clin. Invest.116(6), 1514–1524 (2006).
   PubMed Web of Science ®Google Scholar
• Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature434(7037), 1093–1097 (2005).
   PubMed Web of Science ®Google Scholar
• Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med.361(23), 2209–2220 (2009).
   PubMed Web of Science ®Google Scholar
• Pitcher CJ, Quittner C, Peterson DM et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med.5(5), 518–525 (1999).
   PubMed Web of Science ®Google Scholar
• Rosenberg ES, Billingsley JM, Caliendo AM et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science278(5342), 1447–1450 (1997).
   PubMed Web of Science ®Google Scholar
• Sethi KK, Naher H, Stroehmann I. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature335(6186), 178–181 (1988).
   PubMed Web of Science ®Google Scholar
• Hammond SA, Bollinger RC, Stanhope PE et al. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J. Exp. Med.176(6), 1531–1542 (1992).
   PubMed Web of Science ®Google Scholar
• Stanhope PE, Clements ML, Siliciano RF. Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine. J. Infect. Dis.168(1), 92–100 (1993).
   PubMed Web of Science ®Google Scholar
• Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes. J. Immunol.150(10), 4672–4686 (1993).
   PubMed Web of Science ®Google Scholar
• Miskovsky EP, Liu AY, Pavlat W et al. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. J. Immunol.153(6), 2787–2799 (1994).
   PubMed Web of Science ®Google Scholar
• Appay V. The physiological role of cytotoxic CD4+ T-cells: the holy grail? Clin. Exp. Immunol.138(1), 10–13 (2004).
   PubMed Web of Science ®Google Scholar
• Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med.337(18), 1267–1274 (1997).
   PubMed Web of Science ®Google Scholar
• Norris PJ, Moffett HF, Yang OO et al. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4+ T cells. J. Virol.78(16), 8844–8851 (2004).
   PubMed Web of Science ®Google Scholar
• Kundu SK, Merigan TC. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes. AIDS6(7), 643–649 (1992).
   PubMed Web of Science ®Google Scholar
• Heinkelein M, Euler-Konig I, Klinker H, Ruckle-Lanz H, Jassoy C. Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo. J. Infect. Dis.174(1), 209–213 (1996).
   PubMed Web of Science ®Google Scholar
• Chea S, Dale CJ, De Rose R, Ramshaw IA, Kent SJ. Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J. Virol.79(6), 3748–3757 (2005).
   PubMed Web of Science ®Google Scholar
• Sacha JB, Giraldo-Vela JP, Buechler MB et al. Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. Proc. Natl Acad. Sci. USA106(24), 9791–9796 (2009).
   PubMed Web of Science ®Google Scholar
• Zheng N, Fujiwara M, Ueno T, Oka S, Takiguchi M. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages. J. Virol.83(15), 7668–7677 (2009).
   PubMed Web of Science ®Google Scholar
• Streeck H, Li B, Poon AF et al. Immune-driven recombination and loss of control after HIV superinfection. J. Exp. Med.205(8), 1789–1796 (2008).
   PubMed Web of Science ®Google Scholar
• Kuroda MJ. Macrophages: do they impact AIDS progression more than CD4 T cells? J. Leukoc. Biol.87(4), 569–573 (2010).
   PubMed Web of Science ®Google Scholar
• Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity26(1), 79–92 (2007).
   PubMed Web of Science ®Google Scholar
• Goulder PJ, Phillips RE, Colbert RA et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med.3(2), 212–217 (1997).
   PubMed Web of Science ®Google Scholar
• Ciurea A, Hunziker L, Martinic MM, Oxenius A, Hengartner H, Zinkernagel RM. CD4+ T-cell-epitope escape mutant virus selected in vivo. Nat. Med.7(7), 795–800 (2001).
   PubMed Web of Science ®Google Scholar
• Eckels DD, Zhou H, Bian TH, Wang H. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Int. Immunol.11(4), 577–583 (1999).
   PubMed Web of Science ®Google Scholar
• Rychert J, Saindon S, Placek S, Daskalakis D, Rosenberg E. Sequence variation occurs in CD4 epitopes during early HIV infection. J. Acquir. Immune Defic. Syndr.46(3), 261–267 (2007).
   PubMed Web of Science ®Google Scholar
• Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med.2(3), 338–342 (1996).
   PubMed Web of Science ®Google Scholar
• Benlahrech A, Harris J, Meiser A et al. Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc. Natl Acad. Sci. USA106(47), 19940–19945 (2009).
   PubMed Web of Science ®Google Scholar
• Mattapallil JJ, Douek DC, Buckler-White A et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J. Exp. Med.203(6), 1533–1541 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor GS, Haigh TA, Gudgeon NH et al. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma. J. Virol.78(2), 768–778 (2004).
   PubMed Web of Science ®Google Scholar
• Ribeiro SP, Rosa DS, Fonseca SG et al. A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules. PLoS ONE5(6), e11072 (2010).
   Google Scholar
• Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL. CD4+ T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J. Virol.75(21), 10421–10430 (2001).
   PubMed Web of Science ®Google Scholar
• Moingeon P, Haensler J, Lindberg A. Towards the rational design of Th1 adjuvants. Vaccine19(31), 4363–4372 (2001).
   PubMed Web of Science ®Google Scholar
• Hildeman D, Yanez D, Pederson K, Havighurst T, Muller D. Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease. J. Virol.71(12), 9672–9678 (1997).
   PubMed Web of Science ®Google Scholar
• Fu Z, Cannon MJ. Functional analysis of the CD4+ T-cell response to Epstein–Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression. J. Virol.74(14), 6675–6679 (2000).
   PubMed Web of Science ®Google Scholar